Warren Brooks

Company: Calliditas Therapeutics

Job title: Vice President Medical Affairs

Seminars:

Panel Discussion | Evaluating the Evolving Treatment Landscape for IgA Nephropathy: What Happens Next as More & More Therapies Emerge? 2:45 pm

As more approvals emerge within the IgAN landscape, how will the evolving standard of care make showing efficacy on top of these other therapies harder? It may require multiple therapies with distinct MOAs to optimally treat the patient with IgAN; how can industry best help enhance further knowledge about the efficacy and safety of potential…Read more

day: Pre-Conference Seminar Day